Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

719
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
719
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

592
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
592

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Answering real-world clinical questions using large language model, retrieval-augmented generation, and agentic systems.

Digital health·2025
Same author

Spatial distribution of Mycobacterium tuberculosis mRNA and secreted antigens in acid-fast negative human antemortem and resected tissue.

EBioMedicine·2024
Same author

Novel Insights into the Pathogenesis of Human Post-Primary Tuberculosis from Archival Material of the Pre-Antibiotic Era, 1931-1947.

Pathogens (Basel, Switzerland)·2023
Same author

Detection of <i>Mycobacterium tuberculosis</i> in human tissue via RNA <i>in situ</i> hybridization.

bioRxiv : the preprint server for biology·2023
Same author

COVID-19 and Early Post-Primary TB: Commonalities of Pathobiology in Pneumonitis and Therapies.

Annals of clinical and laboratory science·2023
Same author

<i>Review:</i> Mammalian Target of Rapamycin (mTOR) Pathway Is Critical in Developing Most Renal Cell Tumors.

Annals of clinical and laboratory science·2023
Same journal

Mechanistic constraints in dengue severity: a systematic review with evidence stratification and agent-based evaluation of logical sufficiency.

Frontiers in immunology·2026
Same journal

Circadian control of immune homeostasis in cardiovascular health and disease.

Frontiers in immunology·2026
Same journal

An IHC-derived TLS-CD8-macrophage immune niche score predicts major pathological response to neoadjuvant chemoimmunotherapy in resectable NSCLC.

Frontiers in immunology·2026
Same journal

AF6 orchestrates macrophage polarization via JAK2-STAT3 signaling and supports intestinal regeneration by stimulating stem cell proliferation.

Frontiers in immunology·2026
Same journal

Restoring immune homeostasis in the spinal microenvironment: targeting mechano-inflammation and immunometabolic reprogramming.

Frontiers in immunology·2026
Same journal

A self-perpetuating neuron-intrinsic GSDMD-mtDNA-AIM2 inflammasome axis drives neuronal pyroptosis and cognitive impairment after traumatic brain injury.

Frontiers in immunology·2026
See all related articles

Related Experiment Video

Updated: Mar 7, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.3K

Morphoproteomic-Guided Host-Directed Therapy for Tuberculosis.

Robert E Brown1, Robert L Hunter1, Shen-An Hwang1

  • 1Department of Pathology and Laboratory Medicine, McGovern Medical School, University of Texas Health Science Center at Houston , Houston, TX , USA.

Frontiers in Immunology
|February 18, 2017
PubMed
Summary
This summary is machine-generated.

Developing new tuberculosis (TB) therapies requires understanding disease progression. Morphoproteomics on lung tissue can reveal why some TB lesions regress while others advance, guiding host-directed treatment strategies.

Keywords:
COX-2host-directed therapymTORmorphoproteomicstuberculosis

More Related Videos

A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening
15:28

A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening

Published on: January 17, 2014

8.2K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

9.2K

Related Experiment Videos

Last Updated: Mar 7, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.3K
A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening
15:28

A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening

Published on: January 17, 2014

8.2K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

9.2K

Area of Science:

  • Immunology
  • Pathology
  • Biochemistry

Background:

  • Tuberculosis (TB) therapy research focuses on host-directed approaches to enhance the body's immune response.
  • Understanding adult TB pathogenesis is crucial for developing effective treatments, but current knowledge is limited.
  • Recent findings identify early TB lung lesions as focal endogenous lipid pneumonia, indicating localized susceptibility.

Purpose of the Study:

  • To propose morphoproteomics as a key method for analyzing human TB lung tissue.
  • To leverage morphoproteomic data for identifying metabolic pathways and guiding host-directed therapeutic selection.
  • To bridge the gap in understanding TB lesion progression and spontaneous regression.

Main Methods:

  • Utilizing immunohistochemistry to study human TB lung lesions.
  • Applying morphoproteomics to characterize protein expression within lung tissues.
  • Analyzing metabolic pathways associated with TB lesion development and regression.

Main Results:

  • Spontaneous regression of most TB lesions suggests inherent host defense mechanisms.
  • Morphoproteomics offers a detailed protein expression profile of TB lesions.
  • Identifying factors differentiating progressive vs. regressing lesions is feasible.

Conclusions:

  • Morphoproteomics is a promising approach for dissecting TB pathogenesis at a molecular level.
  • This technique can identify specific host targets for novel therapeutic interventions.
  • Understanding lesion dynamics is key to advancing host-directed TB therapies.